ETF Quote Details
|NAV (month end)||NA|
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
|Dividend (Yield)||$0.39 (0.14%)|
The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by the Funds Index Provider, NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements.
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index